-
Mashup Score: 3
Momelotinib improved OS vs best available therapy in patients with ruxolitinib-experienced myelofibrosis, according to data from a MAIC analysis.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3
Momelotinib improved OS vs best available therapy in patients with ruxolitinib-experienced myelofibrosis, according to data from a MAIC analysis.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Data from an unmatched analysis demonstrated that the median OS favored patients with myelofibrosis who received momelotinib vs those who received best available therapy. #ASH24 #MedTwitter Read more: https://t.co/R2egEfX9TB https://t.co/0QLRNSs81f
-
-
Mashup Score: 1Highlights of ASH in Asia-Pacific - 18 day(s) ago
Join the world’s leading hematology experts at Highlights of ASH in Asia-Pacific, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and non-malignant hematology. February 22-23, 2025 PACIFICO Yokohama | Yokohama, Japan By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the
Source: www.hematology.orgCategories: General Medicine News, Oncologists1Tweet-
Get the latest practice-changing hematology updates from #ASH24, tailored for the Asia-Pacific region, at the only official 2025 Highlights of ASH in Asia-Pacific! Experience interactive discussions & small-group networking 🤝 Register: https://t.co/6m4X1XK947 #medtwitter https://t.co/GkkL6ku3lq
-
-
Mashup Score: 10Highlights of ASH® - 20 day(s) ago
Get a synopsis of the top hematology research presented at the latest ASH annual meeting and learn how it can help improve your patient management and care strategies at Highlights of ASH.
Source: www.hematology.orgCategories: General Medicine News, Oncologists1Tweet-
Seats are filling fast for Highlights of ASH in North America and Asia-Pacific! These 2-day events are right around the corner. Level up your patient care with cutting-edge insights from #ASH24! Register now: https://t.co/zvOUVOJQa4 #MedTwitter https://t.co/rj4Ay15rk1
-
-
Mashup Score: 6Highlights of ASH in North America - 1 month(s) ago
Join the world’s leading hematology experts at Highlights of ASH in North America, a two-day program offered in multiple locations that highlights the most influential research presented at the latest ASH annual meeting. Registration is now open! New York, New York | January 10-11, 2025 Seattle, Washington | January 10-11, 2025 Chicago, Illinois | January 17-18, 2025 Washington D.C. | January 31-February 1, 2025 By attending Highlights of ASH, you will get a comprehensive review of significant scientific
Source: www.hematology.orgCategories: General Medicine News, Oncologists1Tweet-
The breakthrough science of #ASH24 is coming to a city near you! Join leading experts to translate insights from standout abstracts into actionable strategies for your patients. Learn more about Highlights of ASH and our early bird discount! https://t.co/2GDtlN4Bsf #MedTwitter https://t.co/pXEi2BbLxP
-
-
Mashup Score: 11Stay up to date on the latest in Hematology - Hematology.org - 2 month(s) ago
Stay up to date on the latest in Hematology
Source: www.hematology.orgCategories: General Medicine News, Oncologists1Tweet-
🎧 New Episode! "Inside ASH 2024: Insights from the Education Program Co-Chairs” Join the #ASH24 Education Program Co-Chairs Drs. Koreth and Naik to explore the planning process and strategic goals that shaped the program! 🔗 https://t.co/MVbC3TeMsq #MedTwitter @redcell_doc https://t.co/Eg4PbUcCkV
-
-
Mashup Score: 16Highlights of ASH® - 2 month(s) ago
Get a synopsis of the top hematology research presented at the latest ASH annual meeting and learn how it can help improve your patient management and care strategies at Highlights of ASH.
Source: www.hematology.orgCategories: General Medicine News, Oncologists1Tweet-
🩸 🌏 Highlights of ASH is bringing the latest in hematology from #ASH24 to you. Join us in Morocco, Uruguay, and Japan! After just two days, you’ll walk away with actionable ideas to improve your practice. Learn more & register https://t.co/X2oz7MbfNK #MedTwitter https://t.co/gbUPxcm5Z7
-
-
Mashup Score: 5Highlights of ASH in North America - 2 month(s) ago
Join the world’s leading hematology experts at Highlights of ASH in North America, a two-day program offered in multiple locations that highlights the most influential research presented at the latest ASH annual meeting. Registration is now open! New York, New York | January 10-11, 2025 Seattle, Washington | January 10-11, 2025 Chicago, Illinois | January 17-18, 2025 Washington D.C. | January 31-February 1, 2025 By attending Highlights of ASH, you will get a comprehensive review of significant scientific
Source: www.hematology.orgCategories: General Medicine News, Oncologists1Tweet-
The breakthrough science of #ASH24 is coming to a city near you! Join leading experts to translate insights from standout abstracts into actionable strategies for your patients. Learn more about Highlights of ASH and our early bird discount! https://t.co/2GDtlN4Bsf #MedTwitter https://t.co/pXEi2BbLxP
-
-
Mashup Score: 52Paper: Survival and Engraftment Post Allogeneic Hematopoietic Stem Cell Transplantation: ABO Mismatch Matters in RIC - 2 month(s) ago
Program: Oral and Poster Abstracts Type: Oral Session: 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Risk Adapted Approaches to Reduce Transplant Related Toxicities Hematology Disease Topics & Pathways: Research, Clinical Research, Education, Treatment Considerations, Real-world evidence 1 Princess Margaret Cancer Center, Toronto, ON, Canada 2 Princess Margaret Cancer Center, Toronto, Canada 3 Hans Messner Allogeneic Blood and Marrow Transplant Program,
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
If you are at #ASH24, do attend our oral presentation on Dec 8 🙌🏼 I'll be presenting our data from @pmcancercentre @Hans_BMTProgram The message is clear! ABO mm matters in patients receiving RIC. #MedTwitter https://t.co/rHpJWHVADO https://t.co/wV2SPCPJtt https://t.co/yLEhoaldG0
-
-
Mashup Score: 16Quality Improvement Champions - Hematology.org - 9 month(s) ago
Quality Improvement Champions
Source: www.hematology.orgCategories: General Medicine News, Onc News and JournalsTweet-
📢Calling all clinicians, researchers, nurse practitioners & other hematology medical professionals working on quality improvement📢 You can present your case study at #ASH24! Learn more: https://t.co/3VQfLYSdLA #MedTwitter https://t.co/pUo4zYyXpI
-
Data from an unmatched analysis demonstrated that the median OS favored patients with myelofibrosis who received momelotinib vs those who received best available therapy. #ASH24 #MedTwitter Read more: https://t.co/R2egEfX9TB https://t.co/0QLRNSs81f